Calum A. MacRae, MD, PhD, is a Professor of Medicine at Harvard Medical School, the Director of One Brave Idea (a biomedical innovation program founded by the American Heart Association Verily and AstraZeneca with support from Quest Diagnostics), Vice Chair for Scientific Innovation in the Department of Medicine at Brigham and Women’s Hospital in Boston, a Principal Faculty Member at the Harvard Stem Cell Institute, and an Associate Member at the Broad Institute of Harvard and MIT. He is also the PI of the Apple Health Study.

His research group’s overall focus is the development of systematic approaches combining basic biology with modern technology to uncover novel human disease mechanisms and develop targeted diagnostics and therapeutics. His clinical work is on the genomics of inherited heart disease and undiagnosed diseases. He is the co-founder of Tanaist and of Atman Health which automates accessible components of biomedicine.